​

Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary


Aurinia Pharmaceuticals is owned by 59.14% institutional investors, 7.28% insiders, and 33.58% retail investors. Tang capital management is the largest institutional shareholder, holding 9.85% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.24% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals59.14%7.28%33.58%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management13.04M9.85%$221.36M
Blackrock funding, inc. /de8.59M6.60%$139.04M
Blackrock9.27M6.44%$52.94M
Goldman sachs group5.62M4.25%$95.36M
Nea management company3.97M3.00%$67.37M
Two sigma investments, lp3.47M2.62%$58.84M
Arrowstreet capital, limited partnership2.98M2.29%$48.34M
State street2.59M1.99%$41.98M
Marshall wace, llp1.90M1.46%$30.74M
Lsv asset management1.81M1.39%$29.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management13.04M10.05%$221.36M
Nea management company3.97M4.24%$67.37M
Norris financial group358.04K3.44%$2.78M
Hussman strategic advisors210.00K0.73%$3.40M
Ironwood investment management113.95K0.68%$1.85M
Neo ivy capital management166.84K0.59%$2.70M
Uniplan investment counsel272.53K0.43%$4.41M
Virtus investment advisers106.54K0.38%$1.73M
Rice hall james & associates416.63K0.34%$7.07M
Pdt partners265.49K0.24%$4.51M

Top Buyers

HolderShares% AssetsChange
Goldman sachs group5.62M0.01%4.19M
Tang capital management13.04M10.05%814.61K
Lsv asset management1.81M0.05%728.26K
Blackrock9.27M0.00%609.18K
Qube research989.16K0.01%509.19K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.63M
Rock springs capital management lp---1.18M
Man group83.89K0.00%-867.52K
Point72 asset management---849.62K
Readystate asset management lp---657.84K

New Positions

HolderShares% AssetsChangeValue
Hood river capital management269.31K0.04%269.31K$2.98M
Exoduspoint capital management, lp221.62K0.02%221.62K$3.76M
Caption management216.36K0.02%216.36K$3.67M
Neo ivy capital management166.84K0.59%166.84K$2.70M
Dekabank deutsche girozentrale147.54K0.00%147.54K$2.40M

Sold Out

HolderChange
Twin peaks wealth advisors-2.00
Huntington national bank-2.00
Wealth enhancement trust services-5.00
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262905.45%78,287,9805.93%591.96%1558.39%7911.27%
Mar 31, 2026136-50.00%11,979,121-83.37%80.32%68-49.25%32-61.90%
Dec 31, 2025193-23.41%37,728,298-42.57%271.23%98-9.26%56-38.46%
Sep 30, 2025206-10.04%43,375,015-25.50%311.78%86-14.00%7720.31%
Jun 30, 20252271.79%58,203,989-6.12%412.10%99-1.98%646.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF3.01M2.24%-
GS Glb Sm Cp CORE Eq Base Inc USD Snap1.63M1.21%117.90K
Fidelity Small Cap Index1.31M0.97%2.15K
iShares Russell 2000 Growth ETF1.12M0.84%-4.24K
iShares Biotechnology ETF916.81K0.68%-1.74K
Russell 2000 Equity Index Fund B773.72K0.60%17.68K
Russell 2000 Index Non-Lendable Fund773.72K0.60%17.68K
State St Russell Sm/Mid Cp® Indx NL Cl C820.80K0.60%-
State St Russell Sm/Mid Cp® Indx SL Cl I722.20K0.54%-
Vanguard Russell 2000 ETF693.44K0.52%7.92K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2026Robertson Stephen P. Chief Legal OfficerSell$189.52K
Sep 10, 2026Robertson Stephen P. Chief Legal OfficerSell$190.43K
Aug 21, 2026Robertson Stephen P. Chief Legal OfficerSell$355.95K
May 29, 2026TANG KEVIN Chief Executive OfficerBuy$4.02M
Jun 01, 2026TANG KEVIN Chief Executive OfficerBuy$1.52K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q25-
2026 Q16-
2025 Q4--
2025 Q331

AUPH Ownership FAQ


Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 59.14%, followed by 7.28% insiders and 33.58% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 385.89%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (13.04M shares, 9.85%), Blackrock funding, inc. /de (8.59M shares, 6.60%), and Blackrock (9.27M shares, 6.44%). Together, they hold 22.89% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.05% of its assets in 13.04M Aurinia Pharmaceuticals shares, valued at 221.36M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.24% of its total shares outstanding invested in 3.01M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools